On Monday, the FDA published the blog, “FDA Spearheads Global Efforts on Informal Markets and Substandard/Falsified Medical Products.” This blog is the latest in the “From A Global Perspective” series and discusses the FDA’s role in leading WHO efforts to address knowledge gaps regarding the global distribution of substandard and falsified medical products through informal/unregulated markets.